Recall Record

Murrysville, PA, United States

Philips Respironics, Inc. recalls

26 recalls recorded since 2018, most recently on 2 March 2026. 24 are listed as ongoing. Status and classification are as published by the FDA.

Recalls26
Ongoing (FDA)24
Terminated or completed2
Class I (FDA)21

Ongoing Class I Medical devices

Recall started
2 March 2026
Reason
Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
Distribution
Worldwide distribution: US (Nationwide) and OUS (Foreign) to countries of: Argentina, Austria, Australia, Bosnia and Herzegovina, Bangladesh, Belgium, Bulgaria, Bolivia, Brazil, Bahamas, Canada, Switzerland, Chile, China, Colombia, Czech Republic, Germany, Denmark, Algeria, Ecuador, Estonia, Egypt,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1617-2026, Z-1616-2026, Z-1615-2026, Z-1614-2026

Ongoing Class I Medical devices

Recall started
2 March 2026
Reason
In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.
Distribution
Worldwide Distribution. US Nationwide, Argentina, Austria, Australia, Bosnia and Herzegovina, Bangladesh, Belgium, Bulgaria, Bolivia, Brazil, Bahamas, Canada, Switzerland, Chile, China, Colombia, Czech Republic, Germany, Denmark, Algeria, Ecuador, Estonia, Egypt, Spain, Finland, France, Georgia, Fr
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1647-2026, Z-1649-2026, Z-1648-2026, Z-1646-2026

Ongoing Class II Medical devices

Recall started
7 October 2025
Reason
Certain serial numbers of the SimplyGo Mini standard battery kit contain a defective chip which can lead the battery to either fail to charge or lose voltage output when in use in the device. If the fault occurs while the device is running on battery power, the SimplyGo Mini will shut down and stop providing oxygen to the user. This may happen at a temperature within the specified operating temperature range of the SimplyGo Mini.
Distribution
US Nationwide distribution in the states of GA, ID, KY, NJ, NY and the country of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-0481-2026

Ongoing Class I Medical devices

Recall started
30 June 2025
Reason
Devices may possess a programming error resulting in an incorrect device configuration.
Distribution
Worldwide - US Nationwide in the states of AL, CA, CO, FL, GA, IN, LA, MD, NE, NJ, NY, PA, TX & DC. The country of France.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2228-2025, Z-2229-2025, Z-2227-2025

Ongoing Class I Medical devices

Recall started
9 May 2025
Reason
This device does not indicate for use in patients with respiratory failure.
Distribution
Worldwide distribution: US (Nationwide)including Guam and Puerto Rico; OUS (Foreign) to countries of: United Arab Emirates (AE), Argentina (AR), Austria (AT), Australia (AU), Bosnia and Herzegovina (BA), Belgium (BE), Brazil (BR), Canada (CA), Chile (CL), China (CN), Colombia (CO), Costa Rica (CR),
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2037-2025, Z-2035-2025, Z-2036-2025

Ongoing Class I Medical devices

Recall started
7 October 2024
Reason
Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.
Distribution
Worldwide distribution - US Nationwide and the countries of AE, AF, AR, AT, AU, BD, BE, BG, BH, BO, BR, BS, CA, CH, CL, CN, CO, CZ, DE, DK, DZ, EC, EE, EG, ES, FI, FR, GB, GE, GF, GI, GR, GT, HK, HR, HU, ID, IE, IL, IN, IT, JE, JO, JP, KE, KR, KW, LB, LT, LY, MA, ME, MK, MM, MQ, MT, MX, MY, NG, NL,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0292-2025, Z-0293-2025, Z-0294-2025, Z-0295-2025, Z-0296-2025, Z-0290-2025, Z-0291-2025

Ongoing Class I Medical devices

Recall started
16 July 2024
Reason
Firm has released a mandatory software update Version 1.05.10.00 and a User Manual addendum for affected ventilators. These updates resolve safety issues identified in earlier recalls.
Distribution
Worldwide distribution: US (nationwide) and OUS (foreign) countries of: AU, BD, BE, BG, BO, BR, BS, CH, CL, NL, CN, CO, CZ, DE, DK, FR, SE, GB, GF, GR, GT, HK, HR, HU, IE, IL, IN, IT, JP, KE, KW, LB, LT, MA, ME, MA, MT, MQ, MX, NO, NP, OM, PA, PE, PF, PK, PL, PT, PY, QA, RE, RO, RS, RU, SA, SE, SI,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2944-2024, Z-2943-2024, Z-2942-2024

Ongoing Class I Medical devices

Recall started
1 April 2024
Reason
Device may experience an interruption or loss of therapy in case of a Ventilator Inoperative alarm. This may lead to hypoventilation, mild to severe hypoxemia, hypercarbia, respiratory failure/insufficiency, or potentially death.
Distribution
US Nationwide distribution and OUS International distribution to Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-1817-2024

Ongoing Class I Medical devices

Recall started
26 March 2024
Reason
Potential for devices to experience interruption/loss of therapy during a Ventilator Inoperative alarm. This may lead to hypoventilation, mild to severe hypoxemia, hypercarbia, respiratory failure/insufficiency, or potentially death in the most vulnerable patients.
Distribution
Worldwide distribution. US Nationwide including PR and GU; Austria, Belgium, Cyprus, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Portugal, Romania, Serbia, Slovakia, Spain, and Turkey.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1812-2024, Z-1813-2024, Z-1814-2024

Ongoing Class I Medical devices

Recall started
19 March 2024
Reason
Potential for sudden loss of ventilation due to Battery Depleted or Loss of Power alarm while unit has sufficient power.
Distribution
Domestic: Nationwide Distribution; Foreign: AE, AR, AT, AU, BD, BE, BG, BO, BR, BS, CA, CH, CL, CN, CO, CZ, DE, DK, DZ, EC, EE, EG, ES, FI, FR, GB, GE, GF, GI, GR, GT, HK, HR, HU, ID, IE, IL, IN, IT, JE, JO, JP, KE, KR, KW, LB, LT, MA, ME, MK, MM, MQ, MT, MX, MY, NG, NL, NO, NP, NZ, OM, PA, PE, PF,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1505-2024, Z-1501-2024, Z-1499-2024, Z-1503-2024, Z-1502-2024, Z-1500-2024, Z-1504-2024

Ongoing Class II Medical devices

Recall started
27 November 2023
Reason
The following was missing from the Contraindications Statement: The AVAPS-AE therapy mode is contraindicated for invasive use and patients less than 10 kg. The AVAPS feature is contraindicated for patients less than 10 kg. Potential harms if devices are used on contraindicated patients include barotrauma, hypoventilation/hypercapnia, and rebreathing of excessive CO2.
Distribution
Worldwide distribution: US (nationwide)-AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY, Including PR; and OUS (International) including countries of: AE, AR
Initiated
Voluntary: Firm initiated
Recall number
Z-0638-2024

Ongoing Class I Medical devices

Recall started
25 August 2023
Reason
Power Management PCBAs may malfunction, causing a power failure leading to ventilator loss of function.
Distribution
US Distribution to states of: OH, CA, SC, OR; and OUS country of: Philippines.
Initiated
Voluntary: Firm initiated
Recall number
Z-2631-2023

Ongoing Class II Medical devices

Recall started
25 May 2023
Reason
There are errors present in the Korean Instructions For Use where the word "invasive," was incorrectly translated to "noninvasive".
Distribution
Foreign Distribution: Korea.
Initiated
Voluntary: Firm initiated
Recall number
Z-2106-2023

Ongoing Class I Medical devices

Recall started
1 May 2023
Reason
Environmental debris may accumulate on the internal machine flow sensor causing partial occlusion which may impact accurate delivery of pressure, volume, or flow. A malfunction caused by this issue can result in patient harm up to hypoxemia if not addressed by the care provider.
Distribution
US Nationwide. Global Distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1651-2023, Z-1649-2023, Z-1652-2023, Z-1650-2023

Ongoing Class I Medical devices

Recall started
1 March 2023
Reason
The accuracy of delivered oxygen may deviate below the required tolerance of 5% from setpoint when providing high concentration oxygen therapy. Additionally, if equipped, the internal FiO2 sensor may indicate a value higher than the device is actually delivering. This may lead to under delivery of oxygen.
Distribution
Worldwide distribution. US Nationwide including Puerto Rico, and countries of AE, AR, AT, AU, BD, BE, BG, BO, BR, CA, CH, CL, CN, CO, CZ, DE, DK, EC, EE, EG, ES, FI, FR, GB, GE, GT, HK, HR, HU, ID, IL, IE, IN, IT, JP, KW, LB, LT, MM, MQ, MX, MY, NG, NL, NO, NP, NZ, PE, PF, PH, PK, PL, PT, QA, RO,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1288-2023, Z-1289-2023, Z-1287-2023

Ongoing Class I Medical devices

Recall started
10 February 2023
Reason
A limited number of remediated Philips DreamStation units may experience communication issues when connecting to the cloud-based care management application. Should this be the case, this may affect the ability to download prescription settings to the device or the device may have incorrect prescription settings for the patient.
Distribution
US Nationwide. France, Reunion.
Initiated
Voluntary: Firm initiated
Recall number
Z-1322-2023

Ongoing Class I Medical devices

Recall started
7 December 2022
Reason
The replacement silicone sound abatement foam installed into some Trilogy 100 and Trilogy 200 devices may separate from the plastic backing to which it is attached. If this were to happen, the foam could potentially block air inlet, which could result in a reduction in delivered therapy volume or pressure and could cause the device to alarm.
Distribution
US Nationwide and Global Distribution to countries of: Australia, Brazil, Canada, China, Germany, Japan, Korea, and Latin America.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0882-2023, Z-0883-2023, Z-0884-2023

Ongoing Class I Medical devices

Recall started
6 September 2022
Reason
No contraindication/warning regarding magnetic components in CPAP masks for patients with implantable devices or metallic splinters in the eyes.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1783-2022, Z-1782-2022, Z-1780-2022, Z-1784-2022, Z-1781-2022

Ongoing Class I Medical devices

Recall started
26 August 2022
Reason
Motor assemblies manufactured with nonconforming plastic that contributes to off-gassing of VOCs.
Distribution
Domestic: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, ND, NH, NJ, NV, NY, OH, OK, OR, PA, TN, TX, VA, VT, WA, WI, WV, & WY. Foreign: Australia, Austria, Bangladesh, Brazil, Canada, China, Denmark, Egypt, France, Germany, Hong Kong, Hungary, In
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1654-2022, Z-1656-2022, Z-1658-2022, Z-1659-2022, Z-1655-2022, Z-1657-2022

Ongoing Class I Medical devices

Recall started
22 December 2021
Reason
Philips has identified a specific lot of non-conforming material manufactured by one of its suppliers. A Philips supplier incorrectly used polyester-based polyurethane (PE-PUR) sound abatement foam, a non-conforming material in the devices and repair kits. PE-PUR foam may degrade into particles which may enter the device s air pathway and be ingested or inhaled by the user. The foam degradation may be exacerbated by use of unapproved cleaning methods such as unapproved ozone cleaners, and the PE-PUR foam may off-gas certain chemicals during initial use of the device.
Distribution
Worldwide Distribution: Distributed to the following US states: AR, CO, FL, IA, IL, KY, LA, MI, MT, OH, PA, TN, TX, UT, VA, WV, and WY; and Distributed to the following foreign countries: Argentina, Brazil, Romania, and Netherlands.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0493-2022, Z-0494-2022

Ongoing Class II Medical devices

Recall started
26 July 2021
Reason
Two software issues have been identified related to pressure increase in the device: The first issue is described as "Infant/Pediatric EFS Calibration Pressure Increase" and the second issue is described as "Pressure Drift (Continuous Usage).
Distribution
Worldwide distribution - US nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2290-2021, Z-2288-2021, Z-2289-2021, Z-2287-2021

Ongoing Class I Medical devices

Recall started
14 June 2021
Reason
The polyester-based polyurethane (PE-PUR) foam may degrade into particles which may enter the devices air pathway and be ingested or inhaled by the user, and the PE-PUR foam may off-gas certain chemicals.
Distribution
Worldwide distribution including US Nationwide, Argentina, Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, and Latin America.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1956-2021, Z-1958-2021, Z-1957-2021

Ongoing Class I Medical devices

Recall started
14 June 2021
Reason
The polyester-based polyurethane (PE-PUR) foam may degrade into particles which may enter the device s the air pathway and be ingested or inhaled by the user, and the PE-PUR foam may off-gas certain chemicals.
Distribution
Global distribution
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1972-2021, Z-1974-2021, Z-1973-2021

Terminated Class II Medical devices

Recall started
6 April 2021
Terminated
17 January 2024
Reason
Certain devices were built with motor assemblies that could contain non-conforming plastic material. This could result in 1. Exposure to off-gassing of Volatile Organic Compounds not normally present creating a potential biosafety or toxicological hazard and 2. Sudden failure of the device causing a Ventilator Inoperative condition with the potential for asphyxia if not immediately identified and addressed by the care provider.
Distribution
Distribution US nationwide to states of: LA, PA, WI, CO, WV, WA, CA, TX, MO, OK, FL, and TN. Brazil, China, and Japan
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1627-2021, Z-1629-2021, Z-1628-2021, Z-1630-2021, Z-1626-2021, Z-1625-2021

Terminated Class I Medical devices

Recall started
19 November 2019
Terminated
31 March 2021
Reason
Software defect in the Trilogy EVO and Trilogy EVO Universal Ventilator, versions SW 1.00.05, SW 1.01.09.00, SW 1.01.10.00, and SW 1.01.11.00, causing inoperative and loss of all power alarms. This defect causes an incorrect or unexpected result failing requirements TSRS1298 and PRD439.
Distribution
US: None OUS: CH DE DK IT FR IE GB KW QA PL ES AT PH AE SI CZ
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0948-2020, Z-0949-2020, Z-0945-2020, Z-0943-2020, Z-0946-2020, Z-0954-2020, Z-0950-2020, Z-0953-2020, Z-0944-2020, Z-0952-2020, Z-0947-2020, Z-0942-2020 and 1 more

Ongoing Class I Medical devices

Recall started
12 June 2018
Reason
In 2018, Philips Respironics added foam replacement to the preventive maintenance schedule for these devices after discovering the polyester-based polyurethane (PE-PUR) foam may degrade into particles. This 2018 correction has been superseded by the device removal and rework described in Philips Respironics 2021 recall action for the same devices.
Distribution
Global Distribution. US Nationwide.
Initiated
Voluntary: Firm initiated
Recall number
Z-0785-2022

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.